# Long Term Outcome on Brain and Lung of Different Oxygen Strategies in ARDS Patients

> **NCT03621293** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 259 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Modulation of Inspired Fraction of Oxygen (FiO2)

## Key facts

- **NCT ID:** NCT03621293
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-20
- **Primary completion:** 2021-03-20
- **Final completion:** 2021-09-20
- **Target enrollment:** 259 (ESTIMATED)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03621293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03621293, "Long Term Outcome on Brain and Lung of Different Oxygen Strategies in ARDS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03621293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*